These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33413428)

  • 1. Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study.
    Kumarathurai P; Sajadieh A; Anholm C; Kristiansen OP; Haugaard SB; Nielsen OW
    Cardiovasc Diabetol; 2021 Jan; 20(1):12. PubMed ID: 33413428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial.
    Bizino MB; Jazet IM; Westenberg JJM; van Eyk HJ; Paiman EHM; Smit JWA; Lamb HJ
    Cardiovasc Diabetol; 2019 Apr; 18(1):55. PubMed ID: 31039778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus.
    Kozakova M; Morizzo C; Fraser AG; Palombo C
    Cardiovasc Diabetol; 2017 Jun; 16(1):78. PubMed ID: 28623932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction.
    Gökçe M; Karahan B; Erdöl C; Kasap H; Ozdemirci S
    Am J Ther; 2003; 10(2):104-11. PubMed ID: 12629588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study.
    Kumarathurai P; Anholm C; Nielsen OW; Kristiansen OP; Mølvig J; Madsbad S; Haugaard SB; Sajadieh A
    Cardiovasc Diabetol; 2016 Jul; 15(1):105. PubMed ID: 27455835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.
    Lambadiari V; Pavlidis G; Kousathana F; Varoudi M; Vlastos D; Maratou E; Georgiou D; Andreadou I; Parissis J; Triantafyllidi H; Lekakis J; Iliodromitis E; Dimitriadis G; Ikonomidis I
    Cardiovasc Diabetol; 2018 Jan; 17(1):8. PubMed ID: 29310645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction.
    Yagi K; Imamura T; Tada H; Chujo D; Liu J; Shima Y; Ohbatake A; Miyamoto Y; Okazaki S; Ito N; Nakano K; Shikata M; Enkaku A; Takikawa A; Honoki H; Fujisaka S; Origasa H; Tobe K
    J Diabetes Res; 2021; 2021():8838026. PubMed ID: 33855087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic improvement with short-term, glucagon-like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Bojer AS; Sørensen MH; Bjerre J; Gaede P; Vejlstrup N; Madsen PL
    Diabetes Obes Metab; 2021 Oct; 23(10):2374-2384. PubMed ID: 34189832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.
    Yamada H; Tanaka A; Kusunose K; Amano R; Matsuhisa M; Daida H; Ito M; Tsutsui H; Nanasato M; Kamiya H; Bando YK; Odawara M; Yoshida H; Murohara T; Sata M; Node K;
    Cardiovasc Diabetol; 2017 May; 16(1):63. PubMed ID: 28490337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triphasic mitral inflow velocity with mid-diastolic flow: the presence of mid-diastolic mitral annular velocity indicates advanced diastolic dysfunction.
    Ha JW; Ahn JA; Moon JY; Suh HS; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Eur J Echocardiogr; 2006 Jan; 7(1):16-21. PubMed ID: 16378917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of early alterations in transmitral diastolic flow and tissue Doppler findings of the Basal segments of both ventricles in early period after coronary angioplasty].
    Tümüklü M; Kayikçioğlu M; Aliyev E; Cinar CS; Soydan I
    Anadolu Kardiyol Derg; 2003 Mar; 3(1):16-23, AXVII-AXVIII. PubMed ID: 12626305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-dependency of the E/e' ratio in predicting invasive left ventricular filling pressure in patients with suspected or ascertained coronary artery disease.
    Galderisi M; Rapacciuolo A; Esposito R; Versiero M; Schiano-Lomoriello V; Santoro C; Piscione F; de Simone G
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):555-61. PubMed ID: 23103948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial.
    Jørgensen PG; Jensen MT; Mensberg P; Storgaard H; Nyby S; Jensen JS; Knop FK; Vilsbøll T
    Diabetes Obes Metab; 2017 Jul; 19(7):1040-1044. PubMed ID: 28188972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
    Anholm C; Kumarathurai P; Pedersen LR; Samkani A; Walzem RL; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
    Atherosclerosis; 2019 Sep; 288():60-66. PubMed ID: 31326727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of mitral annulus excursion with tissue Doppler echocardiography (tissue Doppler echocardiography = TDE). Noninvasive assessment of left ventricular, diastolic dysfunction].
    Bruch C; Marin D; Kuntz S; Schmermund A; Bartel T; Schaar J; Erbel R
    Z Kardiol; 1999 May; 88(5):353-62. PubMed ID: 10413858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diastolic function in type 2 diabetes after a six month liraglutide treatment.
    Saponaro F; Sonaglioni A; Rossi A; Montefusco L; Lombardo M; Adda G; Arosio M
    Diabetes Res Clin Pract; 2016 Aug; 118():21-8. PubMed ID: 27485853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.
    Anholm C; Kumarathurai P; Klit MS; Kristiansen OP; Nielsen OW; Ladelund S; Madsbad S; Sajadieh A; Haugaard SB;
    BMJ Open; 2014 Jul; 4(7):e005942. PubMed ID: 25031198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
    McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
    Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue Doppler imaging adds incremental value in predicting exercise capacity in patients with congestive heart failure.
    Terzi S; Sayar N; Bilsel T; Enc Y; Yildirim A; Ciloğlu F; Yesilcimen K
    Heart Vessels; 2007 Jul; 22(4):237-44. PubMed ID: 17653517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.